Yang Fei, Zhang Wei
Department of Burns, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, 430060, China.
Aesthetic Plast Surg. 2025 Aug 18. doi: 10.1007/s00266-025-05136-9.
Hypertrophic scars (HS) are the result of abnormal tissue repair after dermal tissue trauma. Their histological characteristics are fibroblast proliferation and excessive deposition of extracellular matrix. This study aimed to identify the role of autologous fat granule (AFG) combined with platelet-rich plasma (PRP) in HS formation and its possible mechanism through in vivo experiments.
A rat wound healing HS model was established, and AFG and PRP alone or in combination treated HS model rats. After 8 weeks of intervention, HS tissues were collected for HE staining, VG staining, immunohistochemistry, ELISA and Western blot analysis.
AFG treatment could significantly inhibit angiogenesis and hypertrophic scar proliferation in HS tissue, and reduce collagen fiber content and inflammatory cell infiltration, and the above changes were more significant when combined with PRP treatment, indicating that AFG combined with PRP treatment had a better therapeutic effect in HS animal model. In addition, AFG treatment can significantly reduce the expression of TGFBRI and Smad3 proteins in HS tissues, and compared with AFG alone, AFG combined with PRP treatment can further reduce the expression of TGFBRI and Smad3 proteins in HS tissues.
AFG combined with PRP can reduce inflammatory cell infiltration and collagen fiber content in HS tissue, and inhibit angiogenesis and scar proliferation, which may be related to inhibiting the activation of TGF-β/Smad signaling pathway. Our study provides a reference for the clinical treatment of HS.
No level of evidence is needed for Basic Science, Animal Study, and Experimental Study Articles. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
肥厚性瘢痕(HS)是真皮组织创伤后异常组织修复的结果。其组织学特征为成纤维细胞增殖和细胞外基质过度沉积。本研究旨在通过体内实验确定自体脂肪颗粒(AFG)联合富血小板血浆(PRP)在HS形成中的作用及其可能机制。
建立大鼠伤口愈合HS模型,分别用AFG、PRP单独或联合处理HS模型大鼠。干预8周后,收集HS组织进行苏木精-伊红(HE)染色、维多利亚蓝(VG)染色、免疫组织化学、酶联免疫吸附测定(ELISA)和蛋白质印迹分析。
AFG治疗可显著抑制HS组织中的血管生成和肥厚性瘢痕增殖,降低胶原纤维含量和炎性细胞浸润,与PRP联合治疗时上述变化更显著,表明AFG联合PRP治疗在HS动物模型中具有更好的治疗效果。此外,AFG治疗可显著降低HS组织中转化生长因子βⅠ型受体(TGFBRI)和Smad3蛋白的表达,与单独使用AFG相比,AFG联合PRP治疗可进一步降低HS组织中TGFBRI和Smad3蛋白的表达。
AFG联合PRP可减少HS组织中的炎性细胞浸润和胶原纤维含量,抑制血管生成和瘢痕增殖,这可能与抑制转化生长因子β(TGF-β)/Smad信号通路的激活有关。本研究为HS的临床治疗提供了参考。
基础科学、动物研究和实验研究文章不需要证据水平。本期刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述,请参阅目录或在线作者指南www.springer.com/00266 。